Relationship between lenalidomide dose modification, duration of therapy, and long-term outcomes in patients with myelodysplastic syndromes

Amy E. DeZern, Gary Binder, Quanhong Ni, Michael McGuire, B. Douglas Smith

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Relationship between lenalidomide dose modification, duration of therapy, and long-term outcomes in patients with myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences